Skip to main content

Marta Sese Faustino

Institutions of which they are part

Postdoctoral researcher
Translational Molecular Pathology
Vall Hebron Institut de Recerca

Marta Sese Faustino

Institutions of which they are part

Postdoctoral researcher
Translational Molecular Pathology
Vall Hebron Institut de Recerca

Projects

Targeting the MNK/eIF4E axis in cancer: a rational approach to enhance tumor sensitivity to chemo- and immunotherapy.

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Maria Rosa Somoza Lopez de Haro, Teresa Moline Marimon, Josep Castellví Vives, Marta Sese Faustino, Stefan Hummer
Funding agency: Instituto de Salud Carlos III
Funding: 123420
Reference: PI20/01687
Duration: 01/01/2021 - 31/12/2023

Efectos bifásicos y formas truncadas de la Cx43 en cáncer de mama: aplicaciones pronósticas y terapéuticas

IP: Trond Aasen
Collaborators: Jordi Temprana Salvador, Teresa Moline Marimon, Marta Sese Faustino
Funding agency: Instituto de Salud Carlos III
Funding: 92565
Reference: PI16/00772
Duration: 01/01/2017 - 30/06/2021

Anatomia Patològica (GRC)

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Cleofé Romagosa Pérez-Portabell, Inés de Torres Ramirez, Angel García Jiménez, Josep Castellví Vives, Maria Teresa Salcedo Allende, Javier Hernandez Losa, Marta Sese Faustino, Vicente Peg Camara, Irene Sansano Valero, Stefania Landolfi , Trond Aasen
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding:
Reference: 2014 SGR 1131
Duration: 01/01/2014 - 31/12/2016

Nuevas estrategias terapéuticas para el cáncer de mama: uso de inhibidores de las MNKs y caracterización de nuevos factores que confieren resistencia al estrés celular.

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Maria Rosa Somoza Lopez de Haro, Jordi Temprana Salvador, Roso Marès Pagès, Teresa Moline Marimon, Josep Castellví Vives, Maria Teresa Salcedo Allende, Marta Sese Faustino
Funding agency: Instituto de Salud Carlos III
Funding: 272552.5
Reference: PI14/01320
Duration: 01/01/2015 - 31/03/2018

Related news

The grants promote new therapeutic strategies and diagnostic tools in highly complex tumors such as glioblastoma, triple-negative breast cancer, and endometrial cancer.

The Department of Health of the Generalitat de Catalunya grants subsidies for carrying out validation tests on innovative projects in the field of health that are in the early stages of development.

The meeting was an opportunity to get to know projects from both institutions and to promote interaction between professionals.

Related professionals

Herimar Meneses Fuenmayor

Herimar Meneses Fuenmayor

Gestió i Administració
Quality, Processes and Document Management Unit
Digital Transformation Directorate
Read more
Andres Rodrigo Parra  Rojas

Andres Rodrigo Parra Rojas

Predoctoral researcher
Infectious Diseases
Read more
Novica Nikolic

Novica Nikolic

Research assistant
Clinical Research/Innovation in Pneumonia & Sepsis (CRIPS)
Read more
María Viñas I Casas

María Viñas I Casas

Predoctoral researcher
Protein kinases in cancer research
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.